Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Ранг среди акций #14517
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Цена акции
$0.87120957
Рыночная капитализация
$405.07M
Изменение (1 день)
-0.64%
Изменение (1 год)
57.03%
Страна
SE
Торговля Egetis Therapeutics AB (publ) (EGTX)

Категория

Коэффициент P/B для Egetis Therapeutics AB (publ) (EGTX)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Egetis Therapeutics AB (publ), текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Egetis Therapeutics AB (publ) с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.828 -
US
7.5116 -
NL
3.9942 -
AU
8.2199 -
US
- -
CH